LIFEVEST WCD 4000 SYSTEM
Report
- Report Number
- 3008642652-2011-00326
- Event Type
- Death
- Date Received
- July 29, 2011
- Date of Event
- June 22, 2011
- Report Date
- July 29, 2011
- Manufacturer
- ZOLL LIFECOR CORPORATION
- Product Code
- MVK
- PMA / PMN Number
- P010030
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- NOT APPLICABLE
Narratives
DEVICE EVAL SUMMARY: DEVICE EVAL OF MONITOR (B)(4) HAS BEEN COMPLETED. THE REPORTED PROBLEM (PT DEATH) HAS BEEN INVESTIGATED. UPON EVAL, THE MONITOR WAS FULLY FUNCTIONAL. RESULTS OF DEATH ANALYSIS: THE DEVICE PROPERLY DETECTED VT/VF; HOWEVER, NO TREATMENT SEQUENCE WAS INITIATED AS THE PT'S VT (122 BPM) WAS BELOW THE PT'S PROGRAMMED VT THRESHOLD (150 BPM). WHEN THE ARRHYTHMIA DEGRADED TO ASYSTOLE, NO TREATMENT SEQUENCE WAS INITIATED AS ASYSTOLE IS CONSIDERED A NON-SHOCKABLE RHYTHM. SUBSEQUENT MONITORING OF THE PT'S RHYTHM WAS NOT POSSIBLE DUE TO DEVICE DEACTIVATION. THE DEVICE FUNCTIONED AS DESIGNED. NO TREATMENT WAS INITIATED FOR VT OR VF RHYTHMS BECAUSE THE PT'S VT WAS BELOW THE PT'S PROGRAMMED VT. IN ADDITION, THE DEVICE DID NOT TREAT ASYSTOLE BECAUSE THIS IS A NON-SHOCKABLE RHYTHM. HOWEVER, THE MONITOR SHOULD HAVE ALARMED WITH A "CALL AMBULANCE" MESSAGE WHEN THE ASYSTOLE RHYTHM WAS DETECTED. THE ALLEGED REPORT BY THE PT'S DAUGHTER THAT THE DEVICE DID NOT ALARM CANNOT BE CONFIRMED. ALL ALARMS WERE FULLY FUNCTIONAL UPON RECEIPT AT ZOLL.
THE PT EXPERIENCED AN EPISODE OF VT AT 122 BPM WHICH DEGRADED TO VF. THE DEVICE PROPERLY DETECTED VT/ VF BUT NO TREATMENT SEQUENCE WAS INITIATED AS THE PT'S VT RATE WAS BELOW THE PROGRAMMED THRESHOLD OF 150 BPM. THE ARRHYTHMIA EVENTUALLY TRANSITIONED TO ASYSTOLE. THE PT PASSED WHILE IN THE HOSP. THE PT'S DAUGHTER REPORTED THAT THE SYSTEM WAS NOT ALARMING AT THE TIME OF DEATH.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | LIFEVEST WCD 4000 SYSTEM | WEARABLE CARDIOVERTER DEFIBRILLATOR | MVK | ZOLL LIFECOR CORPORATION | WCD 4000 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 72 YR | Death |